MedPath

Complications of pulmonary thromboembolism after rapid performance of the team responsible for pulmonary embolism

Phase 2
Conditions
Pulmonary embolism.
Pulmonary embolism
Registration Number
IRCT20210613051561N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
74
Inclusion Criteria

Age 18 to 75 years old
Diagnosis of pulmonary thromboembolism based on the GENEVA criteria
Patients with high-risk pulmonary embolism
Satisfaction with entering this study

Exclusion Criteria

Dissatisfaction to continue participation in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality rate. Timepoint: After interventions. Method of measurement: Check list.;Time of hospitalization. Timepoint: After interventions. Method of measurement: Check list.;Heart function. Timepoint: After interventions. Method of measurement: Eco cardiography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath